entity

NAD+ decline

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NAD+ decline: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

17Connections

1Hypotheses

5Analyses

15Outgoing

2Incoming

0Experiments

12Debates

No AI portrait yet

Outgoing (15)

Target	Relation	Type	Str
H4K16ac accumulation	causes	mechanism	0.90
aging brains	associated_with	brain_region	0.90
SIRT1 activity	reduces	protein	0.90
SIRT1 activity	inhibits	process	0.90
Age-Associated Pathologies	contributes_to	disease	0.90
aging	associated_with	process	0.90
SIRT1 activity	causes	process	0.90
Nuclear Function Defect	causes	phenotype	0.85
Mitochondrial Function Defect	causes	phenotype	0.85
nuclear dysfunction	causes	process	0.85
mitochondrial dysfunction	causes	process	0.85
neurodegenerative diseases	causes	disease	0.80
neurodegeneration	risk_factor_for	disease	0.70
protective adaptive downregulation	associated_with	mechanism	0.70
Alzheimer disease	biomarker_for	disease	0.70

Incoming (2)

Source	Relation	Type	Str
aging	causes	process	0.90
substantia nigra	associated_with	brain_region	0.70

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
NAD+ Decline and SIRT1 Deficiency Drive Epigenetic Reprogram	0.700	neurodegeneration	What molecular mechanisms drive microgli

Mentioning Analyses (5)

Scientific analyses that reference this entity

test debate

neurodegeneration | 2026-04-15 | 0 hypotheses

Metabolomic signatures of neurodegeneration and energy metabolism dysfunction

neurodegeneration | 2026-04-04 | 0 hypotheses

Investigate mechanisms of epigenetic reprogramming in aging neurons

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.770

epigenetic reprogramming aging neurons

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.790

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 7 hypotheses Top: 0.769

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (12)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

Epigenetic reprogramming of aging neurons represents an active research focus wi

closed · Rounds: 4 · Score: 0.67 · 2026-04-22

Investigate mechanisms of epigenetic reprogramming in aging neurons

closed · Rounds: 4 · Score: 0.79 · 2026-04-22

How do metabolomic alterations in glucose metabolism, mitochondrial function, an

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

closed · Rounds: 4 · Score: 0.75 · 2026-04-16

Related Research

Hypotheses and analyses mentioning NAD+ decline in their description or question text

No additional research found